Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty

Current Opinion in Ophthalmology

Volumn 18, Issue 2, 2007, Pages 140-145

  Stein, Joshua D ^a   Challa, Pratap ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Argon laser trabeculoplasty; Efficacy; Laser trabeculoplasty; Mechanism; Selective laser trabeculoplasty

Indexed keywords

ANTIGLAUCOMA AGENT; TIMOLOL;

ARGON LASER; CELL DIVISION; CLINICAL TRIAL; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT; SURGICAL TECHNIQUE; TRABECULOPLASTY;

GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 33847059207     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328086aebf     Document Type: Review

References (57)

1. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: a pilot study. Arch Ophthalmol 1979; 97:319-322.
2. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995; 60:359-371.
3. Melamed S. Argon laser trabeculoplasty: how does it work? In: Epstein DL, Allingham RR, Schuman JS, editors. Chandler and Grant's glaucoma. 4th ed. Baltimore: Williams and Wilkins; 1997. pp. 466-469.
4. Melamed S, Pei J, Epstein DL. Delayed response to argon laser trabeculoplasty in monkeys: morphological and morphometric analysis. Arch Ophthalmol 1986; 104:1078-1083.
5. de Kater AW, Melamed S, Epstein DL. Patterns of aqueous humor outflow in glaucomatous and nonglaucomatous human eyes: a tracer study using cationized ferritin. Arch Ophthalmol 1989; 107:572-576.
6. Van Buskirk EM, Pond V, Rosenquist RC, Acott TS. Argon laser trabeculoplasty: studies of mechanism of action. Ophthalmology 1984; 91:1005-1010.
7. Melamed S, Pei J, Epstein DL. Short-term effect of argon laser trabeculoplasty in monkeys. Arch Ophthalmol 1985; 103:1546-1552.
8. Ruddat MS, Alexander JR, Samples JR, et al. Early changes in trabecular metalloproteinase mRNA levels in response to laser trabeculoplasty are induced by media borne factors. Invest Ophthalmol Vis Sci (Suppl) 1989; 30:280.
9. Latina MA, DeLeon JM. Selective laser trabeculoplasty. Ophthalmol Clin N Am 2005; 18:409-419.
10. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 2001; 108:773-779.
11. Bylsma SS, Samples JR, Acott TS, Van Buskirk EM. Trabecular cell division after argon laser trabeculoplasty. Arch Ophthalmol 1988; 106:544-547.
12. Acott TS, Samples JR, Bradley JM, et al. Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty. Am J Ophthalmol 1989; 107:1-6.
13. Bylsma SS, Samples JR, Acott TS, et al. DNA replication in the cat trabecular meshwork after argon laser trabeculoplasty in vivo. J Glaucoma 1994; 3:36-43.
14. Dueker DK, Norberg M, Johnson DH, et al. Stimulation of cell division by argon and Nd:YAG laser trabeculoplasty in cynomolgus monkeys. Invest Ophthalmol Vis Sci 1990; 31:115-124.
15. Zhao JC, Grosskreutz CL, Pasquale LR. Argon versus selective laser trabeculoplasty in the treatment of open angle glaucoma. Int Ophthalmol Clin 2005; 45:97-106.
16. Latina MA, Gulati V. Selective laser trabeculoplasty: stimulating the meshwork to mend its ways. Int Ophthalmol Clin 2004; 44:93-103.
17. The Glaucoma Laser Trial (GLT). 2: Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group. Ophthalmology 1990; 97:1403-1413.
18. Agarwal HC, Sihota R, Das C, Dada T. Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients. Br J Ophthalmol 2002; 86:733-736.
19. Amon M, Menapace R, Radax U, et al. Long-term follow-up of argon laser trabeculoplasty in uncontrolled primary open-angle glaucoma: a study with standardized extensive preoperative treatment. Ophthalmologica 1990; 200:181-188.
20. Lotti R, Traverso CE, Murialdo U, et al. Argon laser trabeculoplasty: long-term results. Ophthalmic Surg 1995; 26:127-129.
21. Odberg T, Sandvik L. The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand 1999; 77:176-181.
22. Sharma A, Gupta A. Primary argon laser trabeculoplasty vs pilocarpine 2% in primary open angle glaucoma: two years follow-up study. Indian J Ophthalmol 1997; 45:109-113.
23. Cvenkel B. One-year follow-up of selective laser trabeculoplasty in open-angle glaucoma. Ophthalmologica 2004; 218:20-25.
24. Gracner T. Intraocular pressure reduction after selective laser trabeculoplasty in primary open angle glaucoma. Collegium Antropologicum 2001; 25(Suppl):111-115.
25. Gracner T. Intraocular pressure response of capsular glaucoma and primary open-angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective, comparative clinical trial. Eur J Ophthalmol 2002; 12:287-292.
26. Johnson PB, Katz LJ, Rhee DJ. Selective laser trabeculoplasty: predictive value of early intraocular pressure measurements for success at 3 months. Br J Ophthalmol 2006; 90:741-743.
27. Kajiya S, Hayakawa K, Sawaguchi S. Clinical results of selective laser trabeculoplasty. Nippon Ganka Gakkai Zasshi Japonicae 2000; 104:160-164.
28. Kano K, Kuwayama Y, Mizoue S, Ito N. Clinical results of selective laser trabeculoplasty. Nippon Ganka Gakkai Zasshi 1999; 103:612-616.
29. Kim YJ, Moon CS. One year follow up of laser trabeculoplasty using Q-switched frequency doubled Nd-YAG laser of 523 nm wavelength. Ophthalmic Surg Lasers 2000; 31:394-399.
30. Lai JS, Chua JK, Tham CC, Lam DS. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Exp Ophthalmol 2004; 32:368-372.
31. Lanzetta P, Menchini U, Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol 1999; 83:29-32.
32. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 1998; 105:2082-2088.
33. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, non-randomized pilot study. Arch Ophthalmol 2003; 121:957-960.
34. Nagar M, Howes FW. Selective laser trabeculoplasty: a new approach to open-angle glaucoma management. Paper presented at the American Academy of Ophthalmology Meeting; 21 October 2002; Orlando, Florida.
35. Rozsival P, Kana V, Hovorkova M. Selective laser trabeculoplasty. Ceska a Slovenska Oftalmologie 2004; 60:267-274.
36. Song J, Lee PP, Epstein DL, et al. High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma 2005; 14:400-408.
37. McIlraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 2006; 15:124-130. In this multicenter clinical trial, these investigators compared the effectiveness of SLT versus prostaglandin analogues as primary treatment for OAG. They found SLT to be equally as effective as topical medications. They also showed that SLT can reduce the IOP in the contralateral eye.
38. Damji KF, Shah KC, Rock WJ, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: a prospective randomized clinical trial. Br J Ophthalmol 1999; 83:718-722.
39. Hodge WG, Damji KF, Rock W, et al. Baseline IOP predicts selective laser trabeculoplasty success at 1 year posttreatment: results from a randomised clinical trial. Br J Ophthalmol 2005; 89:1157-1160.
40. Popiela G, Muzyka M, Szelepin L, et al. Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma. Klinika Oczna 2000; 102:129-133.
41. Juzych MS, Chopra V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 2004; 111:1853-1859.
42. Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye 2004; 18:498-502.
43. Pirnazar JR, Kolker A, Wax M, et al. The efficacy of 532nm laser trabeculoplasty. Invest Ophthalmol Vis Sci 1998; 39:S5.
44. Tabak S, de Waad PWT, Lermij HG, et al. Selective laser trabeculoplasty in glaucoma. Invest Ophthalmol Vis Sci 1998; 39:S472.
45. Feldman RM, Katz LJ, Spaeth GL, et al. Long-term efficacy of repeat argon laser trabeculoplasty. Ophthalmology 1991; 98:1061-1065.
46. Richter CU, Shingleton BJ, Bellows AR, et al. Retreatment with argon laser trabeculoplasty. Ophthalmology 1987; 94:1085-1089.
47. Weber PA, Burton GD, Epitropoulos AT. Laser trabeculoplasty retreatment. Ophthalmic Surg 1989; 20:702-706.
48. Grayson DK, Camras CB, Podos SM, Lustgarten JS. Long-term reduction of intraocular pressure after repeat argon laser trabeculoplasty. Am J Ophthalmol 1988; 106:312-321.
49. Starita RJ, Fellman RL, Spaeth GL, et al. The effect of repeating full-circumference argon laser trabeculoplasty. Ophthalmic Surg 1984; 15:41-43.
50. Shah N, Yadav R, Nagar M. Selective laser trabeculoplasty: the effect of enhancement and retreatment on IOP control. Paper presented at the XXIV Congress of the European Cataract and Refractive Surgeons (ESCRS); London; 2006.
51. Chen E, Golchin S, Blomdahl S. A comparison between 90 degrees and 180 degrees selective laser trabeculoplasty. J Glaucoma 2004; 13:62-65.
52. Wilensky JT, Weinreb RN. Low-dose trabeculoplasty. Am J Ophthalmol 1983; 95:423-426.
53. Schwartz LW, Speath GL, Traverso C, et al. Variation of techniques on the results of argon laser trabeculoplasty. Ophthalmology 1983; 90:781-784.
54. Ford BA, Cheema SA, Shafranov G, et al. Predictive factors for response to selective laser trabeculoplasty in glaucoma patients on maximal medical therapy. In: Annual Meeting Abstract Search and Program Planner [on CD-ROM]. Association for Research in Vision and Ophthalmology; 1 May 2005. Abstract 115.
55. Weinand FS, Althen F. Long-term clinical results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma. Eur J Ophthalmol 2006; 16:100-104. A recent study showing SLT to achieve control of IOP in 60% of patients at 1 year and 44% of patients at 4 years.
56. Rinke AR, Hughes BA, Juzych MS, et al. The effectiveness of 180 degree versus 360 degree SLT at 3 months. In: Annual Meeting Abstract Search and Program Planner [on CD-ROM]. Association for Research in Vision and Ophthalmology; 1 May 2005. Abstract 116.
57. Kupin TH, Maldonado RS, Burks R, Gailitis RP. Efficacy of selective laser trabeculoplasty on IOP reduction in glaucoma patients. In: Annual Meeting Abstract Search and Program Planner [on CD-ROM]. Association for Research in Vision and Ophthalmology; 1 May 2005. Abstract 118.